Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03547115
Title A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

marginal zone B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

Voruciclib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.